FDA Inspection 1098842 — Biomat USA, Inc.
The FDA completed an inspection of Biomat USA, Inc. on July 31, 2019 in Columbia, MO. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Biologics.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- July 31, 2019
- Fiscal Year
- 2019
- Product Type
- Biologics
- Project Area
- Blood and Blood Products
- Location
- Columbia, MO (United States)